Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Azvudine efficacy in reducing mortality in COVID-19 patients.
Zhong Z, Liu XF, Zhou XZ, Zhong JN, Zhou LC, Li R, Liu XF. Zhong Z, et al. Among authors: zhou xz. Eur J Med Res. 2024 Dec 26;29(1):625. doi: 10.1186/s40001-024-02220-9. Eur J Med Res. 2024. PMID: 39725989 Free PMC article.
Corrigendum to "Cobalt induces neurodegenerative damages through Pin1 inactivation in mice and human neuroglioma cells" [J Hazard Mater 419 (2021) 126378].
Zheng F, Li Y, Zhang F, Sun Y, Zheng C, Luo Z, Wang YL, Aschner M, Zheng H, Lin L, Cai P, Shao W, Guo Z, Zheng M, Zhou XZ, Lu KP, Wu S, Li H. Zheng F, et al. Among authors: zhou xz. J Hazard Mater. 2025 Jan 5;481:136590. doi: 10.1016/j.jhazmat.2024.136590. Epub 2024 Nov 21. J Hazard Mater. 2025. PMID: 39572344 No abstract available.
Targeting NAMPT-OPA1 for treatment of senile osteoporosis.
Bai CW, Tian B, Zhang MC, Qin Q, Shi X, Yang X, Gao X, Zhou XZ, Shan HJ, Bai JY. Bai CW, et al. Among authors: zhou xz. Aging Cell. 2024 Nov 14:e14400. doi: 10.1111/acel.14400. Online ahead of print. Aging Cell. 2024. PMID: 39543818 Free article.
Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].
Wang J, Zhang N, Han Q, Lu W, Wang L, Yang D, Zheng M, Zhang Z, Liu H, Lee TH, Zhou XZ, Lu KP. Wang J, et al. Among authors: zhou xz. Cancer Lett. 2024 Nov 1;604:217257. doi: 10.1016/j.canlet.2024.217257. Epub 2024 Sep 27. Cancer Lett. 2024. PMID: 39333006 Free article. No abstract available.
317 results